Postbiotic Supplements Market

Postbiotic Supplements Market Size

The global postbiotic supplements market size was estimated at USD 1.7 billion in 2024. The market is expected to grow from USD 2.3 billion in 2025 to USD 12.9 billion in 2034, at a CAGR of 21% according to latest report published by Global Market Insights Inc.

• Postbiotics defined officially by International Scientific Association for Probiotics and Prebiotics (ISAPP) in 2021 as preparations of inanimate microorganisms and/or their components that confer health benefits on the host are circumventing viability constraints by preserving bioactivity ISAPP. Evidence continues to mount for digestive, immune and metabolic endpoints across randomized trials to be used in both healthy and vulnerable populations, helping to strengthen confidence in the market for postbiotic supplements.
  
• The category grows faster than the overall supplement space as non-viable formats access heat-processed applications and simplify distribution benefits all-around for reducing spoilage and creating new channels and regions for products. North America led with 41% share in 2024, while Asia Pacific posted the fastest expansion at 21.9% CAGR in the forecasted period due to increased preventive health adoption, middle-class income growth, and a better awareness of microbiomes. Postbiotic supplements market benefits also from maturing analytics multi-omics, and advanced chromatography enabling developers to standardize doses and monitor batch consistency while strengthening regulatory files.
  
• There is also momentum for clinical validation in the digestive and immune areas, with trials having demonstrated improvements in stool quality, barrier function, and respiratory health metrics in relevant cohorts. This has led to a diversification of products: capsules and powders remain predominant, but functional beverages, bars, and ready-to-eat items are taking a share as manufacturers leverage heat stability to integrate clinically relevant doses into daily nutrition routines.
  

Postbiotic Supplements Market Trends

• Due to safety and stability issues, postbiotics are gaining more acceptance among infants, immunocompromised people, and older adults. Clinical trials on its use in infant nutrition have yielded positive results supporting its pediatric use, normal growth, and digestive health without adverse effects. In older adults, postbiotic metabolites like short-chain fatty acids (SCFAs) are involved in gut barrier integrity and inflammation modulation areas that align well with healthy aging goals. Thus, as clinical positioning develops along with increased education for caregivers, the rate of recommendation by pediatricians and geriatric experts is expected to increase over a medium-term horizon.
  
• Heat stability, following its heat treatment becomes free from the changes in color and flavor to a greater extent than live probiotics, allows a much larger integration of postbiotics into different food and beverage formats, including convenience bars as well as heat-processed food products.
  
• A huge investment has been made by global giants of food and beverage industries for the inclusion of postbiotic actives into mass-market products to push retail penetration and consumer trials. With functional food driving a good share of category revenue, the movement toward 'health in habit' consumption is expected to enhance the frequency of use and aid in the premium positioning of postbiotic supplements in the short to medium horizon.
  
• Improvements in fermentation control, analytical chemistry, and microbiome profiling are making postbiotic formulations more precise and personalized. Defined preparations from inactivated cells to purified metabolites are supported by advanced technologies, including NMR, GC-MS, and LC-MS, to ensure consistency and regulatory compliance. Simultaneously, digital health platforms are beginning to recommend postbiotics based on user-specific gut profiles, guarding adherence and satisfaction.
  

Postbiotic Supplements Market Analysis

Based on product type, the postbiotic supplements market is segmented into complex non-viable microbial preparations (CX), microbial metabolic products (MM), intact non-viable microbial cells (IC), fragmented microbial cells (FC), and specialized formulations. Non-viable microbial preparations (CX) dominated the market with an approximate market share of 27.6% in 2024 and is expected to grow with a CAGR of 20.5% by 2034.

• Complex non-viable microbial preparations (CX), with market share of 27.6% in the year 2024, and is expected to grow at a CAGR of 20.5% until 2034, which shows broad applicability for immune and digestive health use cases in the postbiotic supplements market. These fully inactivated preparations retain cellular structures and metabolites, such that under suitable dosing and characterization, they can match or surpass the targeted endpoints of live probiotic comparators. Manufacturers. being usually reliant on a controlled fermentation method below validated inactivation-often thermal-that retains bioactive structures for downstream formulation in capsules and foods.
  
• Microbial Metabolite (MM) had a 23% market share in 2024 and is projected to grow at a CAGR of 21.1% during 2025-2034 owing to the initiation of brands standardizing doses of SCFAs, peptides, and organic acids for targeting indications and forms of delivery. Intact non-viable microbial cells (ICs) equally showed a 20.9% market share and CAGR of 20.9% in the forecast period. Both segments are expected to gain advantage of the preserved cell wall and surface protein interactions that drive immune signaling.
  
• Fragmented microbial cells (FC), with a 16.3% market share, resulted into fastest growth of 21.6% as fragmentation improves exposure to intracellular bioactive for certain applications. Specialized formulations completed 11.8% of market share at a 21.3% CAGR, including encapsulation and blend formats tailored for pediatric and geriatric dosing in the market.

Based on applications, the postbiotic supplements market is segmented into digestive health support, immune system support, metabolic health support, mental health & cognitive support, skin health & anti-aging. Digestive health support holds the largest market share of 37.8% in 2024 and is expected to grow at a CAGR of 21.4% during 2025 to 2034.

• In 2024, 37.8% market share was held by digestive health support, which is forecasted to grow at 20.9% CAGR through 2034, including evidence of stool quality improvement, epithelial barrier support, and symptom relief in IBS-like presentation via pH modulation or pathogen inhibition. Immune system support is anticipated to hold 25.2% market share with a CAGR of 21.4% during 2025-2034, based on trial data relating to postbiotic use with fewer incidences of respiratory infections and a stronger immune response in specific populations.
  
• Metabolic health support, accounted for 18.0% market share in 2024 and expected to grow with an outstanding growth rate because of SCFA-dependent signaling that influences glucose and lipid metabolism. Mental health and cognitive support accounted for 11.2% market share in 2024 owing to its features such as linking to gut-brain axis pathways like neurotransmitter modulation and balancing the neuroinflammation. Skin health and anti-aging is expected to expand the market in the coming years and develop topical synergies in the market.
  

Based on end user, the postbiotic supplements market is segmented into dietary supplements industry, functional foods & beverages, clinical nutrition, cosmetics & personal care, animal nutrition & feed. Dietary supplements segment dominated the market with an approximate market share of 49.8% in 2024 and is expected to grow with the CAGR of 20.8% by 2034.

• Due to their stability, safety, and compatibility with several formats, bioactive compounds from postbiotics have found their way into formulations from the dietary supplements and functional foods and beverages industry. Food manufacturers are already tapping postbiotic ingredients for fortifying snacks, beverages, and dairy alternatives to meet consumer demand for clean-label and microbiome-friendly products. The supplements arena offers postbiotics in convenient forms, such as capsules, powder, and gummies, for immunity defense and metabolic support. Such applications are made possible because of postbiotics' resilience to processing conditions, thereby opening avenues toward broad innovation and commercial availability.
  
• Postbiotics have become a focused area of interest in clinical nutrition for therapeutic dietary management in conformity with either some form immunoinsufficiency or impairment along with digestive system disorders. Hospitals and care facilities consider safety, along with the therapeutic function the postbiotics may accomplish with respect to gut health without posing risks linked to viable microbes. Cosmetics and personal care brands are now noticing the contribution postbiotics provide to skin microbiome balance and anti-inflammatory effects, both topically and through oral delivery.
  
• The animal nutrition and feed industry has begun to adopt postbiotics for the improvement of gut health and immunity in livestock and pets. The whole postbiotics landscape across all segments is particularly looking at personalized nutrition platforms that have started inclining towards including postbiotics into their personalized offerings because of consumer demand and interest in science-backed wellness solutions.
  

The North America postbiotic supplements market dominated the market with a market share of 41% in 2024.

• In 2024, North America dominated the market with factors such as clinician adoption, high consumer awareness, and strong retail coverage in the U.S. and Canada contributing to this. Postbiotics supplement market U.S. driven expansion into functional beverages and bars is fuelled by clarity in labeling and claim guidelines in dietary supplements. Clean label preference in Canada and a growing interest in immune and digestive health are keeping up the demand for nonviable formats that are non-refrigerated and simplify dosing. It is likely to be anticipated that continuing premiumization in practitioner channels, accompanied by mass market launches, will result in market growth in the forecasted period.
  

U.S. dominates the North America postbiotic supplements market, showcasing strong growth potential.

• U.S. has the largest share in postbiotic supplements in North America region since people are very much interested in microbiome health and preventive wellness. The market demand for postbiotics is particularly high, mainly in dietary supplements and functional foods, wherein postbiotics are now used in clean-label, plant-based, and fortified products. This is in line with changing dietary trends and increasing consumer preference for safe, shelf-stable alternatives for probiotics.
  

Europe postbiotic supplements accounted for USD 497.2 million in 2024 and is anticipated to show lucrative growth over the forecast period.

• Marketability considerations regarding functional foods in Europe may endorse premium brands and B2B ingredient partnerships. Czech and Slovak countries will be flat on this trajectory together with Germany, the UK, France, Spain, and Italy since brands are emphasizing clinically relevant dosing and transparency. As postbiotic definitions and claims continue to get formalized regulations, product registration and cross-border approvals should smoothen, thus extending retail penetration in the market. Retailers are also starting to incorporate microbiome literacy highlighting the differences between live probiotics and preparations without living organisms.
  

Germany dominates the European postbiotic supplements market, showcasing strong growth potential.

• Germany is in the European stronghold concerning postbiotics supplements because of its active research programs and great industry participation in microbiome sciences. Consequently, it would also be introducing postbiotics into more products such as plant protein products and fortified foods that cater to changes in diet or health preference among Germans. Application markets include functional foods and beverages that rely on clean and gut health trends.
  

The Asia Pacific postbiotic supplements is anticipated to grow at a CAGR of 21.9% during the analysis timeframe.

• Asia Pacific stands as the fastest-growing region led by China, India, and Japan, where the confluence of microbiome literacy, traditional fermentation knowledge, and rising health spending of the middle class occurs. In China, the market for postbiotics supplements is scaling through e-commerce and modern trade; India, however, shows strong traction amongst practitioners and pharmacy channels for digestive and immune support.
  

China postbiotic supplements market is estimated to grow with a significant CAGR in the Asia Pacific Postbiotic Supplements materials.

• In postbiotic supplements, China is turning out rapidly into a key geographic growth market with immense emphasis on gut health, immunity, and functional nutrition. Industry research as well as food research applications are leading explorations into paste-based and powder-based compositions of postbiotics for up-market snacks, supplements, and fortified food applications. These are in tandem with the country's national priorities on health innovation and modernization in the diet.
  

Latin America postbiotic supplements market accounted for 4.9% market share in 2024 and is anticipated to show lucrative growth over the forecast period.

• Latin America is scaling up in the postbiotics supplement market. Urbanization, heightened awareness of health, and more access to food and health technologies come in here. People are interested in microbiome-supportive products and health trends, such as plant-based and functional nutrition. These facts lead regional manufacturers to set postbiotics in supplements, fortified foods, or wellness products.
  

Brazil leads the Latin American postbiotic supplements market, exhibiting remarkable growth during the analysis period.

• Brazil is the regional leader in personalized nutrition with a healthy streak of innovation in functional foods. Henceforth, food manufacturers throughout Brazil continually focus on enriching nutrient postbiotics formats into pastes or powders for the busy lifestyle, always searching for healthful choices. This includes snacks, drinks, or dietary supplements, which thoroughly consider gut health and immunity. Brazil is also quite dynamic and considering the scope of innovation friendliness available there, it creates a hub for postbiotic development in Latin America.  
  

Middle East & Africa postbiotic supplements market accounted for 3.5% market share in 2024 and is anticipated to show lucrative growth over the forecast period.

• Currently, there is increasing interest in postbiotic supplements among the Middle East and African nations due to urbanization, growing health awareness, and innovations in food and wellness. Consumers are looking for microbiome-supportive products that will align with the trends of clean-label and functional nutrition. This encourages the food and health sectors at regional levels to develop new possibilities of postbiotic applications for supplements, fortified foods, and clinical nutrition.
  

Saudi Arabia postbiotic supplements market to experience substantial growth in the Middle East and Africa market in 2024.

• Saudi Arabia is poised as highest expectation growth in the food processing, healthcare, and hospitality sectors. The food manufacturers are busy working with nutrient fortified paste and powder-based postbiotic formats that conform with foreseeable changes in dietary habits towards convenience nutrition. These will consist of plant-based, fortified, and personalized nutrition products sold to both retail and institutional markets.  
  

Postbiotic Supplements Market Share

The top 5 companies in postbiotic supplements industry include DSM-Firmenich, Cargill, Incorporated, Archer Daniels Midland (ADM), Kerry Group Plc, Chr. Hansen A/S (now Novonesis). These are prominent companies operating in their respective regions covering 36% of the market share in 2024. These companies hold strong positions due to their extensive experience in market. Their diverse product portfolios, backed by robust production capabilities and distribution networks, enable them to meet the rising demand across various regions.

• DSM-Firmenich is a global science-based health, nutrition, and beauty company that resulted from the merger of DSM and Firmenich. It operates in the food, beverage, personal care, and pharmaceutical sectors.
  
• Cargill, Incorporated company is an international player in the areas of food production, agriculture, financial services, and industrial products. It serves to connect the supply chain from farm-fresh to consumer-grade across many locations.
  
• Archer Daniels Midland (ADM) is an American-based multinational concerns itself with processing crops into food ingredients, animal feed, and biofuels. It is also engaged in agricultural origination, transportation, and processing.
  
• Kerry Group Plc is an Irish multinational catering for taste and nutrition solutions for the food, beverages, and pharmaceutical industries. It develops ingredients and technologies for consumer products.
  
• Chr. Hansen A/S (now Novonesis) is bioscience company specializes in natural ingredients for food, beverages, and dietary supplements. After merger with Novozymes, the company is focusing on microbial and enzyme solutions under the name Novozymes.
  

Postbiotic Supplements Market Companies

Major players operating in the postbiotic supplements industry include:

• DSM-Firmenich
• Cargill, Incorporated
• Archer Daniels Midland (ADM)
• Kerry Group Plc
• Chr. Hansen A/S (now Novonesis)
• Immuse Health (Kirin Holdings/Kyowa Hakko Bio)
• SCD Probiotics
• Biofarma Group
• Probi AB
• Culturelle (i-Health, Inc.)
• VSL Pharmaceuticals
• Ritual
• Metagenics

Postbiotic Supplements Industry News

• In January 2024, Glac Biotech expanded its Hsinchu, Taiwan facility to boost capacity for postbiotic ingredients and finished products to appease APAC demand.
  
• In December 2023, MaryRuth Organics launched Complete Gut Health+, putting together postbiotics with prebiotic fibers and enzymes for multi-prong digestive assistance.
  
• In November 2023, Beekeeper's Naturals introduced a 3-in-1 Complete Gut Health supplement with a science-based marketing strategy primarily around the stability of postbiotics compared with that of live probiotics
  

This postbiotic supplements market research report includes in-depth coverage of the industry, with estimates & forecasts in terms of revenue (USD Million) and volume (Kilo Tons) from 2025 to 2034, for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Complex non-viable microbial preparations (CX)
• Microbial metabolic products (MM)
• Intact non-viable microbial cells (IC)
• Fragmented microbial cells (FC)
• Specialized formulations

Market, By Application

• Digestive health support
• Immune system support
• Metabolic health support
• Mental health & cognitive support
• Skin health & anti-aging

Market, By End Use

• Dietary supplements industry
• Functional foods & beverages
• Clinical nutrition
• Cosmetics & personal care
• Animal nutrition & feed

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe 
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa